Armando has built an AI company over 20 years, deeply focusing on Finance and Trading.He discusses his journey, and also reflects on how generative AI startups can be built in a capital-efficient manner. Great conversation! Sramana Mitra: Let’s start at the very beginning of your story. Where are you from? Where were you born and
According to a recent report, the global enterprise collaboration market is expected to grow 15% to $54.88 billion this year and grow at 14% CAGR to reach $92.4 billion by 2027. Atlassian (Nasdaq: TEAM) recently announced its third quarter results that surpassed market expectations.
This report from CB Insights covers the funding trends in the AI space. While lobal AI funding plunged in the quarter, the number of unicorns was steady. Three Generative AI unicorns joined the club this quarter including Anthropic, Adept, and Character.AI. For this week’s posts, click on the paragraph links.
Sramana Mitra: Data is clearly going to change the pharmaceutical industry. Susan Wood: Similarly to find sites. Here are 50 sites that do high-quality imaging work. We went into this by getting imaging biomarkers. That’s an important thing, but more importantly, there are so many disconnects and inefficiencies in running these trials that our data
If you haven’t already, please study our Bootstrapping Course and Investor Introductions page. Our tried-and-true mantra of Bootstrap First, Raise Money Later rings throughout Dave Elkington’s story. As the Founder of InsideSales.com, he used services to bootstrap a Unicorn that had raised close to $140 million in VC funding when we spoke in 2015. Revenue was scaling 100% year
In case you missed it, you can listen to the recording of this roundtable here:
During this week’s roundtable, our focus was on customer acquisition strategy. Rezeve First up, we had Adrian Ng from Singapore pitch Rezeve, a software for running small services businesses. Youzentech Technologies Next, we had Rajkapoor Singh from Bangalore, India, pitch Youzentech Technologies, a semiconductor chip verification company. You can listen to the recording of this
Sramana Mitra: What is the average deal size? Susan Wood: In phase three, it’s in the order of $3 million to $5 million. I want to mention something else. When patients couldn’t go to a centralized site to get evaluated during COVID, they were shut out. The big push in the industry is what’s called